Sera Prognostics, Inc. (SERA)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$2.09
-1.88%
Mkt Cap $72.62M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+187.1%
Consensus $6.00 vs current $2.09